CNTNAP2 and central nervous system cancer: CNTNAP2 (Contactin-associated protein-like 2), a member of the neurexin family, has been proposed as a tumor suppressor in glioma [44], and in our cohort, CNTNAP2 showed 74 NCCMs with 29 patients having one or more variants.